IL163799A0 - Vegf peptides and their use - Google Patents

Vegf peptides and their use

Info

Publication number
IL163799A0
IL163799A0 IL16379903A IL16379903A IL163799A0 IL 163799 A0 IL163799 A0 IL 163799A0 IL 16379903 A IL16379903 A IL 16379903A IL 16379903 A IL16379903 A IL 16379903A IL 163799 A0 IL163799 A0 IL 163799A0
Authority
IL
Israel
Prior art keywords
vegf peptides
vegf
peptides
sckntdsrckarqlelnertcrcdkprr
fragment
Prior art date
Application number
IL16379903A
Other languages
English (en)
Original Assignee
Ark Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ark Therapeutics Ltd filed Critical Ark Therapeutics Ltd
Publication of IL163799A0 publication Critical patent/IL163799A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL16379903A 2002-04-02 2003-03-28 Vegf peptides and their use IL163799A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0207644.6A GB0207644D0 (en) 2002-04-02 2002-04-02 Peptides and their use
PCT/GB2003/001375 WO2003082918A1 (en) 2002-04-02 2003-03-28 Vegf peptides and their use

Publications (1)

Publication Number Publication Date
IL163799A0 true IL163799A0 (en) 2005-12-18

Family

ID=9934136

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16379903A IL163799A0 (en) 2002-04-02 2003-03-28 Vegf peptides and their use

Country Status (17)

Country Link
US (1) US20060166868A1 (xx)
EP (1) EP1490401B1 (xx)
JP (1) JP2005531527A (xx)
KR (1) KR100641535B1 (xx)
CN (1) CN1642979A (xx)
AT (1) ATE360644T1 (xx)
AU (1) AU2003226515B2 (xx)
CA (1) CA2481253A1 (xx)
DE (1) DE60313444T2 (xx)
ES (1) ES2283799T3 (xx)
GB (1) GB0207644D0 (xx)
IL (1) IL163799A0 (xx)
MX (1) MXPA04009479A (xx)
NO (1) NO20044105L (xx)
PL (1) PL371546A1 (xx)
WO (1) WO2003082918A1 (xx)
ZA (1) ZA200406922B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7795213B2 (en) 2001-12-13 2010-09-14 Posco Methods of contacting β amyloid protein with VEGF
WO2005030243A1 (en) 2003-09-26 2005-04-07 Bristol Myers Squibb Company Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation
CN1904150B (zh) * 2006-08-01 2010-07-28 华东师范大学 一种人胰高血糖素样肽-1衍生物及其固相化学合成
GB0619609D0 (en) * 2006-10-04 2006-11-15 Ark Therapeutics Ltd Compounds and their use
GB0619611D0 (en) 2006-10-04 2006-11-15 Ark Therapeutics Ltd Compounds and their use
CN104774246B (zh) * 2014-03-21 2018-05-04 中山大学附属肿瘤医院 Nrp-1特异性肿瘤靶向多肽及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2874292A (en) * 1991-10-24 1993-05-21 Beth Israel Hospital Association, The Assay for malignant effusions
WO1999030157A2 (en) * 1997-12-09 1999-06-17 Children's Medical Center Corporation Neuropilins in methods for diagnosis and prognosis of cancer
EP1248642A4 (en) * 2000-01-18 2005-05-18 Ludwig Inst Cancer Res PEPTIDOMIMETIC INHIBITOR OF VEGF AND VEGF-C AND -D

Also Published As

Publication number Publication date
EP1490401B1 (en) 2007-04-25
GB0207644D0 (en) 2002-05-15
ATE360644T1 (de) 2007-05-15
AU2003226515B2 (en) 2006-06-08
WO2003082918A1 (en) 2003-10-09
US20060166868A1 (en) 2006-07-27
CN1642979A (zh) 2005-07-20
NO20044105L (no) 2004-10-27
JP2005531527A (ja) 2005-10-20
KR20040099356A (ko) 2004-11-26
KR100641535B1 (ko) 2006-10-31
ZA200406922B (en) 2006-06-28
CA2481253A1 (en) 2003-10-09
DE60313444D1 (de) 2007-06-06
ES2283799T3 (es) 2007-11-01
MXPA04009479A (es) 2005-01-25
PL371546A1 (en) 2005-06-27
DE60313444T2 (de) 2007-08-30
AU2003226515A1 (en) 2003-10-13
EP1490401A1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
AU2003228809A8 (en) Kinase anchor protein muteins, peptides thereof, and related methods
WO2003106491A3 (en) PEPTIDES PENETRATING INTO CELLS
WO2004043382A3 (en) Enhanced variants of erythropoietin and methods of use
EP2360259A3 (en) Promyostatin peptides and methods of using same
AU2003250402A8 (en) Beta-sheet forming peptides and material made thereof
HRP20090245T1 (en) Pyy agonists and uses thereof
HK1080517A1 (en) Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
DE69533704D1 (de) Bradykinin-antagonist peptide mit n-substituierten glycinen
MXPA03010684A (es) Peptidos y el uso de los mismos para oscurecer la piel.
IL163799A0 (en) Vegf peptides and their use
CY1109946T1 (el) Τροποποιημενα πεπτιδια και η χρηση τους για τη θεραπεια αυτοανοσων νοσων
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
NO20040880L (no) Casein avledete peptider og anvendelser derav i terapi.
DK1368372T3 (da) Peptid med affinitet til det virale gp120-protein samt anvendelse deraf
NZ591825A (en) Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating fatigue
DE69932834D1 (de) Chi-Conotoxinpeptide als Inhibitoren neuronaler Amintransporter
AU2381402A (en) Small acid-soluble spore protein and uses thereof
MXPA05008378A (es) Inmunoglobulina anti-intregrina.
SG170757A1 (en) Polypeptide having esterase activity and recombinant esterase and use thereof
GB0220805D0 (en) Peptide monomers and protein structures
NZ510812A (en) Novel peptides
AU8748101A (en) A novel polypeptide, a human protein stat2 and the polynucleotide encoding the polypeptide
GB0323609D0 (en) A peptide,and use of the peptide to assay for sflt-1 protein
ATE305478T1 (de) Topoisomerase-ii inhibitoren
AU9364501A (en) A novel polypeptide, a human protein plp39 and the polynucleotide encoding the polypeptide